近日,国务院医改办会同国家卫生计生委等8部门联合印发《关于在公立医疗机构药品采购中推行“两票制”的实施意见(试行)的通知》(国医改办发[2016]4号)。2017年1月9日,国家卫生计生委举办2017年的首场新闻发布会,有关部门负责人和专家向社会解读了该项政策的有关情况。何为“两票制”《通知》要求,在综合医改试点省(区、市)和公立医院改革试点城市的公立医疗机构要率先在药品采购中推 Recently, the State Medical Reform Office and the State Health and Family Planning Commission and other 8 departments jointly issued the “Notice on the Implementation of the” Two-vote System “Implemented in the Drug Purchase of Public Medical Institutions (Trial Implementation) number). On January 9, 2017, the National Health and Family Planning Commission organized the first press conference in 2017, where relevant department heads and experts interpreted the situation of the policy to the public. What is the ”two-vote system“ ”Notice" requires that in the pilot provinces (autonomous regions and municipalities) and public hospitals reform pilot cities in public medical institutions to take the lead in the drug procurement push